{"id":695417,"date":"2026-07-16T20:17:54","date_gmt":"2026-07-16T20:17:54","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/695417\/"},"modified":"2026-07-16T20:17:54","modified_gmt":"2026-07-16T20:17:54","slug":"mwyngil-therapeutics-to-tackle-obesity-but-without-glp-1s","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/695417\/","title":{"rendered":"Mwyngil Therapeutics to tackle obesity, but without GLP-1s"},"content":{"rendered":"<p class=\"author-bio\">Allison covers what hot startups are getting up to, and who\u2019s financing them. She is also co-host of the weekly biotech podcast, \u201c<a href=\"https:\/\/www.statnews.com\/category\/readout-loud\/\" rel=\"nofollow noopener\" target=\"_blank\">The Readout Loud<\/a>.\u201d You can reach Allison on Signal at AllisonDeAngelis.01.<\/p>\n<p>A new startup is making a bold move in the world of obesity drug development: It\u2019s not working with the GLP-1 target that has taken the world by storm.<\/p>\n<p>Just a few years ago, the term \u201cGLP-1\u201d would have been a foreign concept to most Americans. Now, it\u2019s everywhere \u2014 on billboards, TV advertisements, and magazine articles. Most startups hoping to edge their way into the multibillion-dollar weight loss market <a href=\"https:\/\/www.statnews.com\/2023\/09\/12\/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly\/\" rel=\"nofollow noopener\" target=\"_blank\">have their own GLP-1 drug candidate<\/a>. But not Mwyngil Therapeutics.\u00a0<\/p>\n<p>Mwyngil \u2014 pronounced \u201cmwin-gull\u201d \u2014 is studying ways to spur weight loss without targeting the GLP-1 receptor. That\u2019s what attracted CEO Luba Greenwood, a biotech veteran, to the company. \u201cI was not interested in another \u2018me too\u2019 GLP-1, or GLP-1 plus something. \u2026 That\u2019s not very interesting science,\u201d she told STAT, in her first interview about the company.\u00a0<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/09\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus daily coverage and analysis of the biotech sector \u2014 by subscribing to STAT+.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Allison covers what hot startups are getting up to, and who\u2019s financing them. She is also co-host of&hellip;\n","protected":false},"author":2,"featured_media":695418,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[3252,5237,59,102,236,13214,57202,56,54,55,4405],"class_list":["post-695417","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-biotechnology","tag-drug-development","tag-gb","tag-health","tag-obesity","tag-pharmaceuticals","tag-stat","tag-uk","tag-united-kingdom","tag-unitedkingdom","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/695417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=695417"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/695417\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/695418"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=695417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=695417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=695417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}